ANOSEA
MECLIZINE USP
| NAME | STRENGTH | PACK SIZE | DOSAGE FORM |
|---|---|---|---|
| ANOSEA 50 MG | 50 MG | 50 S | TABLET |
Each film-coated tablet contains Meclizine HCl USP 50 mg.
Anosea (Meclizine HCl) is a first generation piperazine-derivative antihistamine that shows marked protective activity against nebulized histamine and used as an antiemetic.
For the prevention and treatment of nausea, vomiting, dizziness, motion sickness and vertigo.
The usual doses of Anosea (Meclizine HCl) are as follow
Nausea and vomiting: 25-50 mg once daily or as directed by physician.
Motion sickness: 25-50 mg once daily (1/2 or 1 tablets 1 hour before to travel starts, The dose may be repeated every 24 hours during the journey.
Vertigo: 25-100mg daily in divided doses.
Radiotherapy induced Nausea and vomiting: 50 mg (Meclizine Hydrochloride) administered 2 to 12 hours prior to radiotherapy.
Meclizine HCl is contraindicated who have shown hypersensitivity to it.
Patients with asthma, bronchitis, emphysema, enlarged prostate, glaucoma or urinary tract blockage should take Meclizine (like other antiemetics) with caution.
Common side effects are Drowsiness, dry mouth, and on rare occasions, blurred vision have been reported.
Meclizine shows no risk of birth defects or abnormalities when administered during pregnancy. Although Meclizine may excrete into the milk, it causes no harm in nursing babies.
Meclizine may increase the toxicity with CNS depressants, neuroleptics and anticholinergic. Alcohol, sedatives and tranquilizers can increase the drowsiness of the patient
Symptoms: Extreme excitability, seizures, drowsiness and hallucinations. Treatment: Appropriate supportive and symptomatic treatment. Consider dialysis.
Store in a cool (below 30°C) and dry place. Keep away from light and out of reach of children.
Each box contains 5x10's and 10x10's tablet in blister pack.